Nutriband Inc. engages in the development and commercialization of transdermal and topical technologies. Its primary focus is on the pharmaceutical industry, specifically in creating innovative drug delivery systems. One of its notable features is the use of adhesive patches designed to deliver active ingredients directly through the skin, offering a non-invasive alternative to traditional pill or injection-based drug administration. This approach can enhance patient compliance and ensure consistent therapeutic effects. Nutriband targets various sectors, including pain management, smoking cessation, and continuous delivery of medication, aligning with the growing demand for patient-friendly drug delivery solutions. Additionally, the company invests in research and development to diversify its product pipeline and address unmet medical needs. In the financial market, Nutriband Inc. represents a niche segment within the broader pharmaceutical industry, focusing on advanced delivery mechanisms that could potentially revolutionize the way patients receive treatment. By leveraging strategic partnerships and advancements in biotechnology, Nutriband aims to position itself as a significant player in the transdermal drug delivery space.
Website121 South Orange Avenue
Orlando, FL, 32801
United States
Sheridan joins independent journalist Nick Shirley to discuss how Nutriband's AVERSA™ abuse-deterrent technology is designed to help reduce the abuse, misuse, and accidental exposure driving the ongoing epidemicORLANDO, Fla., Sept. 29, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW) today announced that its CEO, Gareth Sheridan, has been featured in a new documentary by independent journalist and filmmaker Nick Shirley examining the ongoing opioid crisis in the United States.
ORLANDO, Fla., Sept. 09, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO, Gareth Sheridan will attend the inaugural Nasdaq LaB Biotech Summit on September 16th. The Summit brings together biotechnology executives, investors, and industry leaders for an evening of thought leadership and networking at Nasdaq MarketSite in New York. About AVERSA™ Abuse-Deterrent Transdermal Technology Nutriband's AVERSA™ abuse-deterrent transdermal technology incorp
Nutriband has received a Notice of Publication from the United States Patent and Trademark Office (USPTO) for commercial brand name trademarks for its lead product, an abuse deterrent fentanyl transdermal system. Once allowed, Nutriband plans to submit its commercial worldwide brand name to the FDA and other international regulatory agencies for approval. ORLANDO, Fla., Sept. 08, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), a company engaged in the development of prescrip
ORLANDO, Fla., Aug. 13, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB)(NASDAQ:NTRBW), today announced that its CEO and Co-Founder, Gareth Sheridan will present at the 2026 Georgia Life Sciences Summit on Aug 26th as part of the CEO spotlight event. The Georgia Life Sciences Summit brings together leaders from across biotechnology, medical technology, research, manufacturing, and investment to showcase Georgia’s emergence as a national leader in life sciences innovation. The Summit takes p
Detailed price information for Nutriband Inc (NTRB-Q) from The Globe and Mail including charting and trades.
Investors talking about NTRBW also mention
| # | Name | Attention |
|---|---|---|
| 1 | Nutriband Inc.NTRB | 0%0 |
| 2 | Invesco DB Agriculture FundDBA | 0.02%+0.01 |
| 3 | Rigetti Computing, Inc.RGTI | 0.01%-0.01 |
| 4 | EDR - Endeavor Group Holdings, Inc. | —— |
| 5 | Applied Digital CorporationAPLD | 0.16%-0.04 |
| 6 | MARA Holdings Inc.MARA | 0.03%-0.02 |
| 7 | Constellation Brands Inc. Class ASTZ | 0%-0.01 |
| 8 | Palo Alto Networks, Inc.PANW | 0.06%-0.09 |
| 9 | UiPath, Inc. Class A Common StockPATH | 0.01%0 |
| 10 | Super Micro Computer Inc.SMCI | 0.09%-0.01 |
What share of all stock conversation is about NTRBW?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% 0 |
Of the messages about NTRBW that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 100% +16.67 | ||
| Bearish | — | — | — | 0% -16.67 |
Of the messages about NTRBW that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Analysts | — | — | — | 43.03% | ||
| Announcements | — | — | — | 0.61% | ||
| Controversies | — | — | — | 0.61% | ||
| Earnings | — | — | — | 12.73% | ||
| Macro | — | — | — | 43.03% | ||
| Technical Analysis | — | — | — | 0% |
Of the messages about NTRBW, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | — | — | 0% | ||
| Newcomers | — | — | — | 100% |